Why is Nath Bio-Genes falling/rising?

As of 11-Jul, Nath Bio-Genes (India) Ltd is experiencing a price increase, currently at 225.70, reflecting a rise of 1.7 (0.76%). The stock has shown a strong performance recently, with a 4.51% increase over the past week and a notable 10.99% rise over the past month. Today's trading saw the stock reach an intraday high of Rs 232, although it also dipped to a low of Rs 215.65. Despite the positive movement, there are concerns regarding falling investor participation, as the delivery volume decreased by 3.49% compared to the five-day average. The stock is trading at a discount relative to its peers, with a price-to-book value of 0.7, which indicates an attractive valuation despite a year-over-year return of -9.63% and an 8% decline in profits.
In the broader market context, while Nath Bio-Genes has outperformed the Sensex by 4.51% over the past week, the benchmark index has declined by 1.12%. This indicates that the stock is gaining traction in a generally unfavorable market for the sector, which has seen a decline of 2.2%. The stock's performance year-to-date shows a 19.89% increase, contrasting with the Sensex's 5.58% rise, further highlighting its relative strength. However, the long-term performance reveals a decline of 31.19% over five years, compared to the Sensex's impressive 125.45% increase, suggesting that while short-term movements are positive, there are underlying challenges that could affect future performance.